Zoetis (ZTS) Cash & Current Investments (2012 - 2026)
Zoetis' (ZTS) quarterly Cash & Current Investments came in at $1.7 billion in Q2 2026, up 16.79% year-over-year from $1.4 billion in Q2 2025, and down 13.65% quarter-over-quarter from $1.9 billion in Q1 2026.
Analysis
Zoetis (ZTS) Cash & Current Investments (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Cash & Current Investments for 15 consecutive years, with $1.7 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash & Current Investments rose 16.79% year-over-year to $1.7 billion in Q2 2026; TTM through Jun 2026 was $1.7 billion, a 16.79% increase from a year earlier, with the FY2025 full-year figure at $2.4 billion, up 23.3% from the prior year.
- Cash & Current Investments was $1.7 billion for Q2 2026 at Zoetis, down from $1.9 billion in the prior quarter.
- Over five years, Cash & Current Investments peaked at $3.6 billion in Q4 2022 and troughed at $1.4 billion in Q2 2025.
- A 5-year average of $2.1 billion and a median of $2.0 billion in 2024 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments slumped 43.0% in 2023 and grew 23.3% in 2025, its largest moves.
- Over 5 years, Cash & Current Investments stood at $3.6 billion in 2022, then tumbled by 43.0% to $2.0 billion in 2023, then declined by 2.65% to $2.0 billion in 2024, then gained by 23.3% to $2.4 billion in 2025, then tumbled by 31.59% to $1.7 billion in 2026.
- The last three Cash & Current Investments figures came in at $1.7 billion (Q2 2026), $1.9 billion (Q1 2026), and $2.4 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.69 Bn | 40.49 Bn | 779.09 Mn | 196.93 Mn |
| 2 | Zoetis | 30.63 Bn | 28.95 Bn | 1.05 Bn | 1.68 Bn |
| 3 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | 530.00 Mn |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn | 81.99 Mn |
| 5 | Immucell | 90.19 Mn | 81.33 Mn | 2.44 Mn | 8.86 Mn |
| 6 | Zhengye Biotechnology Holding | 76.23 Mn | 69.14 Mn | - | 7.10 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 244,235.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.68 Bn |
| Mar 31, 2026 | 1.94 Bn |
| Dec 31, 2025 | 2.45 Bn |
| Sep 30, 2025 | 2.08 Bn |
| Jun 30, 2025 | 1.44 Bn |
| Mar 31, 2025 | 1.72 Bn |
| Dec 31, 2024 | 1.99 Bn |
| Sep 30, 2024 | 1.71 Bn |
| Jun 30, 2024 | 1.57 Bn |
| Mar 31, 2024 | 1.98 Bn |
| Dec 31, 2023 | 2.04 Bn |
| Sep 30, 2023 | 1.75 Bn |
| Jun 30, 2023 | 1.72 Bn |
| Mar 31, 2023 | 2.11 Bn |
| Dec 31, 2022 | 3.58 Bn |
| Sep 30, 2022 | 2.51 Bn |
| Jun 30, 2022 | 2.65 Bn |
| Mar 31, 2022 | 3.14 Bn |
| Dec 31, 2021 | 3.49 Bn |
| Sep 30, 2021 | 3.27 Bn |